Filter
1860
Text search:
malaria
morbidity
Featured
176
671
Language
Document type
1137
294
196
86
79
33
14
12
4
3
2
Countries / Regions
100
75
67
62
62
60
57
56
52
47
46
39
38
38
37
32
29
27
21
20
18
18
18
17
14
13
13
12
11
10
10
10
9
9
8
8
8
7
7
7
7
7
6
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
985
126
121
103
92
39
17
Toolboxes
100
88
79
72
61
58
53
42
34
34
34
32
29
21
17
17
15
13
12
10
9
6
3
3
1
1
NEMLIST | Sixth Edition | February 2016
“towards quality health and social welfare services”
National Tuberculosis and Leprosy Conrol Programme
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
Loss and damage is an urgent concern, driven by the increasingly harmful effects of climate change. Communities are experiencing new types and forms of climate impact, of higher frequency and intensity, which they are not equipped to handle. These impacts compel vulnerable communities to migrate to
...
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
What We Know, What We Don’t Know, and What We Need to Do
